These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 32103952)

  • 1. Targeting Pancreatic Cancer Cells and Stellate Cells Using Designer Nanotherapeutics in vitro.
    Elechalawar CK; Hossen MN; Shankarappa P; Peer CJ; Figg WD; Robertson JD; Bhattacharya R; Mukherjee P
    Int J Nanomedicine; 2020; 15():991-1003. PubMed ID: 32103952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodistribution and therapeutic efficacy of a gold nanoparticle-based targeted drug delivery system against pancreatic cancer.
    Elechalawar CK; Gulla SK; Roy RV; Means N; Zhang Y; Asifa S; Robertson DJ; Xu C; Bhattacharya R; Mukherjee P
    Cancer Lett; 2024 May; 589():216810. PubMed ID: 38494151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent.
    Patra CR; Bhattacharya R; Wang E; Katarya A; Lau JS; Dutta S; Muders M; Wang S; Buhrow SA; Safgren SL; Yaszemski MJ; Reid JM; Ames MM; Mukherjee P; Mukhopadhyay D
    Cancer Res; 2008 Mar; 68(6):1970-8. PubMed ID: 18339879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGFR-Targeted Cationic Polymeric Mixed Micelles for Codelivery of Gemcitabine and miR-205 for Treating Advanced Pancreatic Cancer.
    Mondal G; Almawash S; Chaudhary AK; Mahato RI
    Mol Pharm; 2017 Sep; 14(9):3121-3133. PubMed ID: 28719220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designing nanoconjugates to effectively target pancreatic cancer cells in vitro and in vivo.
    Khan JA; Kudgus RA; Szabolcs A; Dutta S; Wang E; Cao S; Curran GL; Shah V; Curley S; Mukhopadhyay D; Robertson JD; Bhattacharya R; Mukherjee P
    PLoS One; 2011; 6(6):e20347. PubMed ID: 21738572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective targeting of gemcitabine to pancreatic cancer through PEG-cored Flt-1 antibody-conjugated dendrimers.
    Öztürk K; Esendağlı G; Gürbüz MU; Tülü M; Çalış S
    Int J Pharm; 2017 Jan; 517(1-2):157-167. PubMed ID: 27965135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GEM-loaded magnetic albumin nanospheres modified with cetuximab for simultaneous targeting, magnetic resonance imaging, and double-targeted thermochemotherapy of pancreatic cancer cells.
    Wang L; An Y; Yuan C; Zhang H; Liang C; Ding F; Gao Q; Zhang D
    Int J Nanomedicine; 2015; 10():2507-19. PubMed ID: 25848268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibiting the growth of pancreatic adenocarcinoma in vitro and in vivo through targeted treatment with designer gold nanotherapeutics.
    Kudgus RA; Szabolcs A; Khan JA; Walden CA; Reid JM; Robertson JD; Bhattacharya R; Mukherjee P
    PLoS One; 2013; 8(3):e57522. PubMed ID: 23483913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifunctional gold-nanoparticles: A nanovectorization tool for the targeted delivery of novel chemotherapeutic agents.
    Fernandes AR; Jesus J; Martins P; Figueiredo S; Rosa D; Martins LM; Corvo ML; Carvalheiro MC; Costa PM; Baptista PV
    J Control Release; 2017 Jan; 245():52-61. PubMed ID: 27871990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted polyethylene glycol gold nanoparticles for the treatment of pancreatic cancer: from synthesis to proof-of-concept in vitro studies.
    Spadavecchia J; Movia D; Moore C; Maguire CM; Moustaoui H; Casale S; Volkov Y; Prina-Mello A
    Int J Nanomedicine; 2016; 11():791-822. PubMed ID: 27013874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pirfenidone inhibits pancreatic cancer desmoplasia by regulating stellate cells.
    Kozono S; Ohuchida K; Eguchi D; Ikenaga N; Fujiwara K; Cui L; Mizumoto K; Tanaka M
    Cancer Res; 2013 Apr; 73(7):2345-56. PubMed ID: 23348422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gold nanoparticles and radiofrequency in experimental models for hepatocellular carcinoma.
    Raoof M; Corr SJ; Zhu C; Cisneros BT; Kaluarachchi WD; Phounsavath S; Wilson LJ; Curley SA
    Nanomedicine; 2014 Aug; 10(6):1121-30. PubMed ID: 24650884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arsenic trioxide-loaded nanoparticles enhance the chemosensitivity of gemcitabine in pancreatic cancer
    Zhao Y; Yao H; Yang K; Han S; Chen S; Li Y; Chen S; Huang K; Lian G; Li J
    Biomater Sci; 2022 Oct; 10(20):5989-6002. PubMed ID: 36052559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel gemcitabine derivative-loaded liposome with great pancreas-targeting ability.
    Li PW; Luo S; Xiao LY; Tian BL; Wang L; Zhang ZR; Zeng YC
    Acta Pharmacol Sin; 2019 Nov; 40(11):1448-1456. PubMed ID: 31015736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of gemcitabine and retinoic acid loaded PAMAM dendrimer-coated magnetic nanoparticles on pancreatic cancer and stellate cell lines.
    Yalçin S; Erkan M; Ünsoy G; Parsian M; Kleeff J; Gündüz U
    Biomed Pharmacother; 2014 Jul; 68(6):737-43. PubMed ID: 25108345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UTMD-Promoted Co-Delivery of Gemcitabine and miR-21 Inhibitor by Dendrimer-Entrapped Gold Nanoparticles for Pancreatic Cancer Therapy.
    Lin L; Fan Y; Gao F; Jin L; Li D; Sun W; Li F; Qin P; Shi Q; Shi X; Du L
    Theranostics; 2018; 8(7):1923-1939. PubMed ID: 29556365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin-Induced Stromal Depletion to Enhance the Penetration of Gemcitabine-Loaded Magnetic Nanoparticles for Pancreatic Cancer Targeted Therapy.
    Han H; Hou Y; Chen X; Zhang P; Kang M; Jin Q; Ji J; Gao M
    J Am Chem Soc; 2020 Mar; 142(10):4944-4954. PubMed ID: 32069041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. pH-Sensitive Nanodrug Carriers for Codelivery of ERK Inhibitor and Gemcitabine Enhance the Inhibition of Tumor Growth in Pancreatic Cancer.
    Ray P; Dutta D; Haque I; Nair G; Mohammed J; Parmer M; Kale N; Orr M; Jain P; Banerjee S; Reindl KM; Mallik S; Kambhampati S; Banerjee SK; Quadir M
    Mol Pharm; 2021 Jan; 18(1):87-100. PubMed ID: 33231464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paracrine HGF promotes EMT and mediates the effects of PSC on chemoresistance by activating c-Met/PI3K/Akt signaling in pancreatic cancer in vitro.
    Xu J; Liu S; Yang X; Cao S; Zhou Y
    Life Sci; 2020 Dec; 263():118523. PubMed ID: 33039386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretion of fibronectin by human pancreatic stellate cells promotes chemoresistance to gemcitabine in pancreatic cancer cells.
    Amrutkar M; Aasrum M; Verbeke CS; Gladhaug IP
    BMC Cancer; 2019 Jun; 19(1):596. PubMed ID: 31208372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.